XML 29 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock Based Compensation
3 Months Ended
Mar. 31, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Based Compensation

11. Stock Based Compensation—The Company accounts for stock-based awards to employees and directors in accordance with FASB ASC 718, “Share-Based Payment,” which requires the measurement and recognition of compensation for all share-based payment awards made to employees and directors including shares of common stock granted for services, employee stock options, and employee stock purchases related to the Employee Stock Purchase Plan (“employee stock purchases”) based on estimated fair values.

The following tables illustrate the Company’s stock based compensation, unamortized stock-based compensation, and remaining weighted average period for the three months ended March 31, 2017 and 2016.

 

 

 

Stock-Based

Compensation

for the Three

months ended

 

 

Unamortized

Stock-Based

Compensation

 

 

Remaining

Weighted

Average

Period (years)

 

March 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

Incentive Stock Options

 

$

84

 

 

$

293

 

 

 

0.8

 

Restricted Stock

 

 

656

 

 

 

5,438

 

 

 

2.5

 

Performance Based Restricted Stock

 

 

300

 

 

 

2,385

 

 

 

2.5

 

Performance Based Options

 

 

40

 

 

 

128

 

 

 

0.8

 

Total

 

$

1,080

 

 

$

8,244

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

Incentive Stock Options

 

$

89

 

 

$

746

 

 

 

1.7

 

Restricted Stock

 

 

326

 

 

 

1,462

 

 

 

1.4

 

Performance Based Restricted Stock

 

 

33

 

 

 

441

 

 

 

1.3

 

Performance Based Options

 

 

8

 

 

 

263

 

 

 

1.7

 

Total

 

$

456

 

 

$

2,912

 

 

 

 

 

 

Stock Options—During the three months ended March 31, 2017, the Company did not grant any employees options to acquire shares of common stock.

Option activity within each plan is as follows:

 

 

 

Incentive

Stock Option

Plans

 

 

Weighted

Average Price

Per Share

 

 

Exercisable

Weighted

Average Price

Per Share

 

Balance outstanding, December 31, 2016

 

 

541,905

 

 

$

9.33

 

 

$

7.97

 

Options exercised

 

 

(15,000

)

 

 

7.50

 

 

 

 

Options forfeited

 

 

(3,919

)

 

 

11.49

 

 

 

 

Balance outstanding, March 31, 2017

 

 

522,986

 

 

$

9.37

 

 

$

7.99

 

 

Information relating to stock options at March 31, 2017, summarized by exercise price is as follows:

 

 

 

Outstanding Weighted

Average

 

 

Exercisable Weighted

Average

 

Exercise Price Per Share

 

Shares

 

 

Remaining

Life

(Months)

 

 

Exercise

Price

 

 

Shares

 

 

Exercise

Price

 

Incentive Stock Option Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$7.50

 

 

283,350

 

 

 

44

 

 

$

7.5

 

 

 

283,350

 

 

$

7.50

 

$11.32—$14.49

 

 

239,636

 

 

 

89

 

 

$

11.57

 

 

 

34,334

 

 

$

12.07

 

 

 

 

522,986

 

 

 

 

 

 

$

9.37

 

 

 

317,684

 

 

$

7.99

 

 

The weighted average exercise prices for options granted, and exercisable, and the weighted average remaining contractual life for options outstanding as of March 31, 2017, were as follows:

 

As of March 31, 2017

 

Number

of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life

(Months)

 

 

Intrinsic

Value

(thousands)

 

Incentive Stock Option Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding

 

 

522,986

 

 

$

9.37

 

 

 

65

 

 

$

3,783

 

Expected to Vest

 

 

518,897

 

 

$

9.35

 

 

 

65

 

 

$

3,762

 

Exercisable

 

 

317,684

 

 

$

7.99

 

 

 

47

 

 

$

2,734

 

 

During the three months ended March 31, 2017 and 2016, the Company recognized stock-based compensation related to stock options of $84 and $89, respectively.

As of March 31, 2017 and 2016, the Company had approximately $293 and $746, of unamortized stock-based compensation related to unvested stock options outstanding. This amount will be recognized over the weighted-average period of 0.8 and 1.7 years. This projected expense will change if any stock options are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

Common stock grants A summary of non-vested shares as of and for the three months ended March 31, 2017 and 2016 is presented below:

 

 

 

Three Months Ended

March 31, 2017

 

 

Three Months Ended

March 31, 2016

 

 

 

Number

of Shares

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Number

of Shares

 

 

Weighted

Average

Grant

Date Fair

Value

 

Nonvested shares at December 31st

 

 

324,756

 

 

$

14.75

 

 

 

362,841

 

 

$

20.43

 

Granted

 

 

251,475

 

 

 

16.10

 

 

 

 

 

 

 

Vested

 

 

(10,100

)

 

 

12.95

 

 

 

(127,274

)

 

 

31.29

 

Forfeited

 

 

(6,544

)

 

 

15.26

 

 

 

(16,008

)

 

 

23.67

 

Nonvested shares at March 31st

 

 

559,587

 

 

$

15.38

 

 

 

219,559

 

 

$

14.59

 

 

Common stock grants — During the three months ended March 31, 2017, the Company issued a total of 251,475 shares of restricted common stock to employees. The shares will cliff vest after three years of service. The shares granted in 2017 were average fair valued at $16.10 per share.  The fair value was determined by using the publicly traded share price as of the date of grant. The Company will recognize as expense the value of restricted shares over the required service period.

 

During the three months ended March 31, 2016, the Company issued a total of 119,402 shares of restricted common stock to employees. The shares will cliff vest after three years of service. The shares granted in 2016 were average fair valued at $15.10 per share. The fair value was determined by using the publicly traded share price as of the date the grant was approved. The Company will recognize as expense the value of restricted shares over the required service period.  As the shares were subject to stockholder approval at the time the shares were issued, they were excluded from the table above.

During the three months ended March 31, 2017 and 2016, the Company recognized stock-based compensation related to restricted shares of $656 and $326, respectively.

As of March 31, 2017 and 2016, the Company had approximately $5,438 and $1,462, respectively, of unamortized stock-based compensation related to unvested restricted shares. This amount will be recognized over the weighted-average period of 2.5 and 1.4 years. This projected expense will change if any restricted shares are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

Performance Based SharesA summary of non-vested performance based shares as of and for the three months ended March 31, 2017 and 2016, respectively is presented below:

 

 

 

Three Months Ended

March 31, 2017

 

 

Three Months Ended

March 31, 2016

 

 

 

Number

of Shares

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Number

of Shares

 

 

Weighted

Average

Grant

Date Fair

Value

 

Nonvested shares at December 31st

 

 

119,022

 

 

$

14.18

 

 

 

104,403

 

 

$

17.05

 

Granted

 

 

121,194

 

 

 

15.40

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

(9,395

)

 

 

17.65

 

Nonvested shares at March 31st

 

 

240,216

 

 

$

14.80

 

 

 

95,008

 

 

$

16.99

 

 

Performance Based Shares — During the three months ended March 31, 2017, the Company issued a total of 121,194 performance based shares to employees. The shares granted during the first quarter of 2017 have an average fair value of $15.40.  The fair value was determined by using the publicly traded share price as of the date of grant. The Company will recognize as expense the value of the performance based shares over the required service period from grant date. The shares will cliff vest on February 8, 2020 with a measurement period commencing January 1, 2017 and ending December 31, 2019. Eighty percent of these performance based shares are based upon the financial performance of the Company, specifically, an earnings before income tax (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30%. The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2016 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for recording less than the targeted performance and to increase to a maximum of 200% for achieving  in excess of the targeted performance.

During the three months ended March 31, 2016, the Company conditionally granted a total of 52,170 performance based shares that will cliff vest on January 6, 2019 with a measurement period commencing January 1, 2016 and ending December 31, 2018.  The shares granted to management during the first quarter of 2016, were subject to stockholder approval to extend the term of the Company’s stock incentive plan. That approval was received at the stockholder meeting on June 8, 2016. At that point the shares were given a fair value of $14.39. The fair value was determined by using publically traded share price on the date that the shareholders approved the grant.   Eighty percent of these performance based shares are based upon the financial performance of the Company, specifically, an earnings before income tax (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30%. The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2015 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for recording less than the targeted performance and to increase to a maximum of 200% for achieving in of the targeted performance.  As the shares were subject to stockholder approval at the time the shares were issued to management, no expense was recorded during the first quarter of 2016 and the shares were consequently excluded from the table above.

As of March 31, 2017, performance based shares related to earnings before income tax (“EBIT”) and net sales have an average fair value of $16.10 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The performance based shares related to the Company’s stock price have an average fair value of $12.60 per share. The fair value was determined by using the Monte Carlo valuation method. For awards with performance conditions, the Company recognizes share-based compensation cost on a straight-line basis for each performance criteria over the implied service period.

During the three months ended March 31, 2017 and 2016, the Company recognized stock-based compensation related to performance based shares of $300 and $33, respectively.

As of March 31, 2017 and 2016, the Company had approximately $2,385 and $441, respectively, of unamortized stock-based compensation expense related to unvested performance based shares. This amount will be recognized over the weighted-average period of 2.5 and 1.3 years. This projected expense will change if any performance based shares are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

Performance Incentive Stock Options—During the three months ended March 31, 2017 and 2016, the Company did not grant any employees performance incentive stock options to acquire shares of common stock.

Performance option activity is as follows:

 

 

 

Incentive

Stock Option

Plans

 

 

Weighted

Average Price

Per Share

 

 

Exercisable

Weighted

Average Price

Per Share

 

Balance outstanding, December 31, 2016

 

 

82,334

 

 

$

11.49

 

 

$

 

Options forfeited

 

 

 

 

 

 

 

 

 

Balance outstanding, March 31, 2017

 

 

82,334

 

 

$

11.49

 

 

$

 

 

Information relating to stock options at March 31, 2017 summarized by exercise price is as follows:

 

 

 

Outstanding Weighted

Average

 

 

Exercisable Weighted

Average

 

Exercise Price Per Share

 

Shares

 

 

Remaining

Life

(Months)

 

 

Exercise

Price

 

 

Shares

 

 

Exercise

Price

 

Performance Incentive Stock Option Plan:

 

 

82,334

 

 

 

9

 

 

$

11.49

 

 

 

 

 

$

 

 

The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of March 31, 2017 are as follows:

 

As of March 31, 2017

 

Number

of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life

(Months)

 

 

Intrinsic

Value

(thousands)

 

Performance Incentive Stock Option Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding

 

 

82,334

 

 

$

11.49

 

 

 

9

 

 

$

421

 

Expected to Vest

 

 

76,986

 

 

$

11.49

 

 

 

9

 

 

$

393

 

Exercisable

 

 

 

 

$

 

 

 

 

 

$

 

 

During the three months ended March 31, 2017 and 2016, the Company recognized stock-based compensation related to performance stock options of $40 and $8, respectively.

As of March 31, 2017 and 2016, the Company had approximately $128 and $263, respectively, of unamortized stock-based compensation expenses related to unvested performance incentive stock options outstanding. This amount will be recognized over the weighted-average period of 0.8 and 1.7 years. This projected expense will change if any performance incentive stock options are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

In March 2016, FASB issued ASU 2016-09, Compensation—Stock Compensation (Topic 718). The new standard changes the accounting for certain aspects of share-based payments to employees. The standard requires the recognition of the income tax effects of awards in the income statement when the awards vest or are settled, thus eliminating additional paid in capital (“APIC”) pools. The standard also allows for the employer to repurchase more of an employee’s shares for tax withholding purposes without triggering liability accounting. Cash paid by an employer when directly withholding shares for tax-withholding purposes should be classified as a financing activity in the statement of cash flows. In addition, the standard allows for a policy election to account for forfeitures as they occur rather than on an estimated basis. The new standard is effective for fiscal years beginning after December 15, 2016 with early adoption permitted. The Company assessed the impact of the adoption of this new standard and determined there was no material impact on the 2016 consolidated financial statements.  The Company has considered the different options for treatment of forfeitures in accounting for stock compensation and has elected to continue to account for such adjustments on the estimated basis. The Company adopted this new standard prospectively in the current period.  The impact of this adoption was not material.